Is it worth the risk of developing a secondary cancer after ASCT?
In this week’s Ask Dr. Durie, Dr. Brian Durie discusses how to learn about your own risk factors for secondary cancers when undergoing MM treatment.
The BOTTOM LINE:
Know your own risk factors and discuss the pros and cons with your doctor.
If you have a question that you’d like to suggest for a future episode of Ask Dr. Durie, please submit it to [email protected].
To reach the IMF InfoLine Coordinators, please call 800.452.2873 or email them at [email protected].
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.